Bob Dagher is the Chief Medical Officer of WCG – MedAvante-ProPhase (MA-PP). He is a seasoned executive leader with diverse biopharmaceutical roles in clinical development and medical affairs. Prior to joining WCG MA-PP, Bob was the Chief Medical Officer of Cadent Therapeutics in Cambridge, MA. Preceding that, he had occupied multiple leadership roles at small and large biopharmaceutical and clinical research organizations, including GlaxoSmithKline, Genzyme, Sanofi and Covance among others.
Bob has fostered the development of multiple products in different indications and development platforms and advanced several small molecules and biologics across all stages of clinical development. Bob’s background includes therapeutic experience in psychiatry, neurology and rare diseases.
Follow Bob Dagher, MD on social media using the links below: